World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02968342
Date of registration: 16/11/2016
Prospective Registration: No
Primary sponsor: Bezmialem Vakif University
Public title: Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women
Scientific title: Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women
Date of first enrolment: July 2016
Target sample size: 30
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02968342
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Ayse G Karasu, M.D
Address: 
Telephone: 5365144142
Email: agokmenkarasu@bezmialem.edu.tr
Affiliation: 
Name:     Ayse F Karasu
Address: 
Telephone: 5365144142
Email: agokmenkarasu@bezmialem.edu.tr
Affiliation: 
Name:     Serdar G Aydin, M.D
Address: 
Telephone:
Email:
Affiliation:  Bezmialem Üniversitesi Tip Fakültesi Hastanesi
Key inclusion & exclusion criteria

Inclusion Criteria:

- Menopausal status

- Sexually active

Exclusion Criteria:

- Medical history of chronic psychiatric disease

- Medical conditions associated with female sexual dysfunction; cardiovascular disease,
uncontrolled chronic HT (hypertension) ,DM (diabetes mellitus), History of gynecologic
surgery, female gynecological cancer ( breast, ovarian, uterine, cervical)

- Medications associated with female sexual dysfunction; Antidepressants opiates, beta
blockers, Antiepileptics ( gabapentin, topiramate,phenytoin) benzodiazepines



Age minimum: 40 Years
Age maximum: 80 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Sexual Desire Disorder
Menopause
Hypoactive Sexual Desire Disorder
Intervention(s)
Device: Vaginal progesterone 8%
Primary Outcome(s)
FSFI (Female Sexual Function Index) questionnaire "arousal" domain [Time Frame: 1 month]
Secondary Outcome(s)
FSFI (Female Sexual Function Index) questionnaire "lubrication" domain [Time Frame: 1 month]
FSDS-R (Female Sexual Distress Scale- Revised) score [Time Frame: 1 month]
FSFI (Female Sexual Function Index) questionnaire all domains [Time Frame: 1 month]
Secondary ID(s)
18.11.2015-21/35
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history